| #26 |
Frederic Madec |
Ipsen Bioinnovation Limited |
1 |
| #26 |
Greg Kemmitt |
Dow Agrosciences |
1 |
| #26 |
Thomas Martin Krulle |
Prosidion Limited |
1 |
| #26 |
Jonathan Mark Bentley |
Vernalis Research Limited |
1 |
| #26 |
Elaine Harper |
The James Black Foundation Limited |
1 |
| #26 |
Hervé Jean Claude Deboves |
Ucb Biopharma Srl |
1 |
| #26 |
Nathaniel Julius Thomas Monck |
Vernalis Research Limited |
1 |
| #26 |
Craig Johnstone |
Astrazeneca Ab |
1 |
| #26 |
Peter Randall |
Viavi Solutions Uk Limited |
1 |
| #26 |
Victor Alexandrovich Kalinin |
Transense Technologies, Plc |
1 |
| #26 |
Petra Dieterich |
American Cyanamid |
1 |
| #26 |
Agata B. Swiatek |
Oxis Energy Limited |
1 |
| #26 |
Lee Bowles |
Padlock Therapeutics |
1 |
| #26 |
Paul Beasley |
Siemens Aktiengesellschaft |
1 |
| #26 |
Elise Gadouleau |
Padlock Therapeutics |
1 |
| #26 |
Noel ROCHE |
Faradion Limited |
1 |
| #26 |
Pui Leng Loke |
BOE |
1 |
| #26 |
Trevor Ming-Yee Yeung |
Oxford University |
1 |
| #26 |
Holly Atton |
Padlock Therapeutics |
1 |
| #26 |
Ronald Knegtel |
Vertex Pharmaceuticals Incorporated |
1 |
| #26 |
Nat Monck |
Padlock Therapeutics |
1 |
| #26 |
Jordan Palfrey |
Padlock Therapeutics |
1 |
| #26 |
Philip Stephen Kerry |
Padlock Therapeutics |
1 |
| #26 |
Laura Gleave |
Padlock Therapeutics |
1 |
| #26 |
Karen PARRISH |
BOE |
1 |
| #26 |
Kathrin Skibbe |
Adaptimmune Limited |
1 |
| #26 |
Bruno Laugel |
Adaptimmune Limited |
1 |
| #26 |
Carl Leslie North |
Padlock Therapeutics |
1 |
| #26 |
Aimee Cossins |
Ipsen Bioinnovation Limited |
1 |
| #26 |
Stéphane Pintat |
Chroma Therapeutics |
1 |
| #26 |
Sophie Catherine COOPER |
Disarm Therapeutics |
1 |
| #26 |
Pierre-Henri Storck |
Vertex Pharmaceuticals Incorporated |
1 |
| #26 |
Shelley Anne Parrott |
Disarm Therapeutics |
1 |